Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial
Purpose: The primary objective was to assess the acute efficacy of 0.25% reproxalap ophthalmic solution versus vehicle in patients with dry eye disease. Design: This was a vehicle-controlled, randomized-sequence, double-masked, 2-period crossover trial. Participants and Controls: Sixty-three patient...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2026-01-01
|
| Col·lecció: | Ophthalmology Science |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2666914525002362 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|